A follow-on open-label study examining effects of 1 month of intranasal oxytocin dosing did show a reduction in pain, but a more impressive decrease in the frequency of headaches in both chronic and high frequency episodic migraineurs [104]. This evidence concerns the gene OXT and Headache.